FDA Approves Novel Gene Therapy for Spinal Muscular Atrophy in Newborns: 95% Success in Preventing Severe Symptoms
FDA fast-tracks gene therapy for spinal muscular atrophy in newborns, boasting 95%…
FDA Approves Revolutionary mRNA Flu Vaccine with 90% Efficacy in Late-Stage Trials
FDA grants emergency approval to Moderna's mRNA flu vaccine with 90% efficacy…
FDA Approves Updated RSV Vaccine for High-Risk Adults, Accelerating Winter Respiratory Prep
FDA's emergency approval of updated RSV vaccine targets high-risk adults amid rising…
Eli Lilly Alzheimer’s Drug Trial Delivers 40% Slowdown in Cognitive Decline: Phase 3 Results Spark FDA Fast-Track Hopes
Eli Lilly's phase 3 trial for new Alzheimer's drug shows 40% slowdown…
FDA Approves Groundbreaking RSV Vaccine for Infants Under 6 Months Amid Record Winter Surge
FDA emergency approves new RSV vaccine for infants under 6 months as…
FDA Approves Moderna’s Pioneering mRNA Flu Vaccine for 2025-26 Season: A New Era in Influenza Protection
FDA approves Moderna's first mRNA flu vaccine for 2025-26, offering broader protection…
FDA Approves Revolutionary mRNA Flu Vaccine with 95% Efficacy Against Dominant H3N2 Strain
FDA approves mRNA flu vaccine with 95% efficacy vs. H3N2 strain amid…
FDA Approves Revolutionary Gene Therapy for Rare Neuromuscular Disease, Achieving 80% Efficacy in Halting Progression
FDA fast-tracks gene therapy for rare neuromuscular disorder XLMTM, with 80% efficacy…
CRISPR Breakthrough: Gene Editing Achieves Complete Cure for Sickle Cell Disease in Landmark FDA Trials
FDA-approved CRISPR trials achieve complete remission in sickle cell patients, revolutionizing gene…
Breakthrough: CRISPR Gene Editing Cures Sickle Cell Disease in Landmark Phase 3 Trials
A CRISPR gene editing therapy has cured sickle cell disease in phase…
